Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2023 Feb 20;45(4):e433–e440. doi: 10.1097/MPH.0000000000002636

TABLE 1.

Participant demographics, medical information, and HRQOL

Variable n (%) or M ± SD Range
Youth Age 13.17 ± 3.09 8.00-18.60
Youth Gender
 Female 25 (40)
 Male 38 (60)
Youth Race and Ethnicity
 Black/African American 61 (97)
 Asian 1 (2)
 Hispanic or Latino/a 1 (2)
Youth SCD Genotype
 HbSS or HbSβ0 43 (68)
 HbSC and HbSβ+ 20 (32)
Youth Hemoglobin 9.77 ± 1.92 2.68-13.50
Youth SCD-Related Treatment
 Chronic Transfusions 8 (13)
 Hydroxyurea 29 (46)
Youth Stroke History
 Overt Stroke 3 (5)
 Silent Cerebral Infarction 7 (11)
Youth Hospital Utilization
 Hospitalizations 0.70 + 1.12 0-5
 Emergency Department Visits 0.84 + 2.29 0-17
Caregiver Age 39.30 ± 8.68 24-63
Caregiver Gender
 Female 57 (90)
 Male 6 (10)
Caregiver Race/Ethnicity
 Black/African American 60 (95)
 Asian 1 (2)
 Hispanic or Latino/a 1 (2)
 Other 1 (2)
Caregiver Relationship to Youth
 Mother 53 (84)
 Father 5 (8)
 Othera 5 (8)
Caregiver Education: Highest Grade Completed 13.78 ± 2.42 11-20
Youth HRQOL
 Total Score 65.41 ± 17.28 18.60-99.42
 Worry 2 79.37 ± 28.41 0-100
 Communication 1 72.22 ± 25.53 0-100
 Worry 1 70.32 ± 26.24 0-100
 Treatment 69.33 ± 20.97 21.43-100
 Pain and Hurt 68.39 ± 20.43 19.44-100
 Emotions 67.26 ± 31.94 0-100
 Communication 2 61.64 ± 32.36 0-100
 Pain Impact 55.85 ± 24.17 7.50-100
 Pain Management 55.44 ± 31.58 0-100

Note. HRQOL = Health-Related Quality of Life.

a

“Other” caregivers included 1 grandmother, 1 stepmother, and 3 legal guardians.